Contact this trialFirst, we need to learn more about you.
Procedure
FX-909 for Bladder Cancer
Recruiting1 awardPhase 1
San Antonio, Texas
This trial will study the safety and tolerability of a drug called FX-909 in people with advanced solid tumors, like urothelial carcinoma. Results will show the best dose for patients and any side effects.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.